Intrexon Corp (XON)
$19.07 0.00 (0.00%)
19:55 EDT XON Stock Quote Delayed 15 Minutes
Previous Close -
Market Cap 2.61B
PE Ratio -18.16
Volume (Avg. Vol.)
Day's Range 19.07 - 19.07
52-Week Range -
Dividend & Yield N/A (N/A)
XON Stock Predictions, Articles, and Intrexon Corp News
- From InvestorPlace
- From the Web
These lesser-known companies are all in deep trouble for various reasons, making them ideal small-cap stocks to sell now.
Exxon Mobil has been one of the dominant players in the oil business for many decades. The company has had an up-and-down year, just like the price of oil itself. But after a steep slide in February, the stock price has been on an upswing in recent months.
The overall ratings of 41 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
What are the best stocks to buy right now? We try to answer this question by tracking the moves of smart money and buy side analysts. Here's what's hot...
If you're a fan of growth stocks and healthcare stocks ... well, these seven names would've done you well in 2015. A few of them could keep soaring.
Emerging healthcare companies with novel technologies and drugs is where major growth prospects reside.
Intrexon Corp., LendingClub Corporation and CA Technologies, Inc. used more than their fair share of red ink on Wednesday. Here's the deal.
From Market News Video
Investors in Intrexon Corp (XON) saw new options become available this week, for the December 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XON options chain for the new December 20th contracts and identified one put and one call contract of particular interest.
From Simply Wall St
The external fund manager backed by Berkshire Hathaway’s Charlie Munger, Li Lu, makes no bones about it when he says ‘The biggest investment risk is not the volatility of prices,<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-xon/intrexon/news/heres-why-intrexon-nasdaqxon-can-afford-some-debt/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!